These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 39899)

  • 21. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of obsidan on hemodynamics and phase indices (at rest and during physical load in patients with hypertensive disease)].
    Gaevskiĭ IuG; Vaĭntsvaĭg PM
    Ter Arkh; 1977; 49(1):96-8. PubMed ID: 867250
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M; Burckhardt D; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1984; 6(3):417-22. PubMed ID: 6202966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of propranolol on central hemodynamics in hypertensive patients at rest and during stress].
    Kästner C; Zott HJ; Wallrabe D
    Z Gesamte Inn Med; 1989 Aug; 44(15):442-5. PubMed ID: 2815888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic responses to supine bicycle exercise in juvenile hypertensive subjects: an echocardiographic assessment (author's transl)].
    Imataka K; Yamaoki K; Oouchi Y; Yazaki Y
    J Cardiogr; 1981 Jun; 11(2):449-56. PubMed ID: 7320526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Human pharmacological studies on the hemodynamic effects of a new beta-adrenergic antagonist (bufuralol-Hcl).
    Magometschnigg D; Korn A; Bonelli J; Hitzenberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R95. PubMed ID: 238156
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacodynamic and pharmacokinetic studies on bufuralol in man.
    Pringle TH; Francis RJ; East PB; Shanks RG
    Br J Clin Pharmacol; 1986 Nov; 22(5):527-34. PubMed ID: 2878678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Larsen JS; Pedersen EB
    Eur J Clin Pharmacol; 1980 Aug; 18(2):135-9. PubMed ID: 7428793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
    Burkart F; Pfisterer M; Steinmann E
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.
    Fitscha P; Meisner W; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):359-62. PubMed ID: 2900143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regional hemodynamic changes induced by muscular exercise in subjects with obliterating arteriopathy of the lower extremities: effect of beta receptor blocking].
    Brevetti G; Paudice G; Lavecchia G; De Caprio L; Ferro G; D'Ascia C; Orefice U
    Boll Soc Ital Cardiol; 1977; 22(7):1094-100. PubMed ID: 36115
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.
    Eckert M; Cocco G; Strozzi C; Heizmann P; Sfrisi C
    Eur J Clin Pharmacol; 1983; 24(4):479-84. PubMed ID: 6134625
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension.
    Krediet RT; Dunning AJ; Offerhaus L
    Eur J Clin Pharmacol; 1980 Nov; 18(5):391-4. PubMed ID: 6108222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamic study of hyperthyroidism and variations induced by propranolol].
    Cayuela ML; Doval H; Bazzino O; Hermberg HC
    Medicina (B Aires); 1977; 37(3):223-31. PubMed ID: 19677
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of obsidan on cardiohemodynamic indicators in hypertension].
    Nazarenko VR
    Vrach Delo; 1976 Sep; (9):50-3. PubMed ID: 10676
    [No Abstract]   [Full Text] [Related]  

  • 39. Bufuralol, a new beta-adrenoceptor blocking agent.
    Fothergill GA; Francis RJ; Hamilton TC; Osbond JM; Parkes MW
    Experientia; 1975 Nov; 31(11):1322-3. PubMed ID: 1287
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effects of beta adrenoceptor antagonists on airways resistance at rest and during exercise in normal subjects [proceedings].
    Davidson C; Kusail AA; Taylor SH
    Br J Clin Pharmacol; 1977 Oct; 4(5):636P-637P. PubMed ID: 20920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.